- Home
- FONR vs NVCT Comparison
FONR vs NVCT Comparison
Compare FONR & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- NVCT
- Stock Information
- Founded
- FONR 1978
- NVCT 2020
- Country
- FONR United States
- NVCT United States
- Employees
- FONR N/A
- NVCT N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- FONR Health Care
- NVCT Health Care
- Exchange
- FONR Nasdaq
- NVCT Nasdaq
- Market Cap
- FONR 95.7M
- NVCT 107.8M
- IPO Year
- FONR 1987
- NVCT 2022
- Fundamental
- Price
- FONR $15.22
- NVCT $5.49
- Analyst Decision
- FONR
- NVCT Strong Buy
- Analyst Count
- FONR 0
- NVCT 1
- Target Price
- FONR N/A
- NVCT $21.00
- AVG Volume (30 Days)
- FONR 9.4K
- NVCT 104.2K
- Earning Date
- FONR 02-12-2025
- NVCT 03-04-2025
- Dividend Yield
- FONR N/A
- NVCT N/A
- EPS Growth
- FONR N/A
- NVCT N/A
- EPS
- FONR 1.42
- NVCT N/A
- Revenue
- FONR $102,006,089.00
- NVCT N/A
- Revenue This Year
- FONR N/A
- NVCT N/A
- Revenue Next Year
- FONR N/A
- NVCT N/A
- P/E Ratio
- FONR $10.70
- NVCT N/A
- Revenue Growth
- FONR 0.70
- NVCT N/A
- 52 Week Low
- FONR $14.05
- NVCT $4.44
- 52 Week High
- FONR $24.05
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- FONR 47.95
- NVCT 49.57
- Support Level
- FONR $15.03
- NVCT $5.34
- Resistance Level
- FONR $15.40
- NVCT $5.89
- Average True Range (ATR)
- FONR 0.29
- NVCT 0.51
- MACD
- FONR 0.03
- NVCT 0.02
- Stochastic Oscillator
- FONR 70.41
- NVCT 33.68
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.